依巴斯汀

Ebastine

未知生产厂商

Ebastine is a second generation H1-receptor antagonist useful in the treatment of allergic rhinitis and urticaria.

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Ebastine is a second generation H1-receptor antagonist useful in the treatment of allergic rhinitis and urticaria.

用于伴有或不伴有过敏性结膜炎的过敏性鼻炎（季节性和常年性）。慢性特发性荨麻疹的对症治疗。

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Prepn of ebastine
申请人: HANGZHOU BAOLING CO LTD优先权: 2006
CN
Nanoparticulate ebastine formulations
申请人: ELAN PHARMA INT LTD优先权: 2006
US
SOLID ORAL FORMS OF EBASTINE
申请人: SIMBEC IBERICA S L优先权: 2005
US
Ebastine tablet and its prepn. method
申请人: AOYI BAOLING PHARMACEUTICAL CO优先权: 2005
CN
Preparation method of ebastine oral solution
申请人: JIANGSU CHENPAI BANGDE PHARMACEUTICAL CO LTD优先权: 2025
CN
Ebastine tablet and preparation method thereof
申请人: SHANGHAI IDEAL PHARMACEUTICAL CO LTD优先权: 2025
CN
Pharmaceutical Compositions Comprising Ebastine and Fluticasone
申请人: MALHOTRA GEENA优先权: 2011
US
Ebastine chewable tablet and preparation method thereof
申请人: VENTUREPHARM JIANGSU CO LTD优先权: 2022
CN